BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36652613)

  • 1. Low expression of E-Cadherin and
    García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
    Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.
    Nasri S; More H; Graziano F; Ruzzo A; Wilson E; Dunbier A; McKinney C; Merriman T; Guilford P; Magnani M; Humar B
    BMC Cancer; 2008 May; 8():138. PubMed ID: 18482459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
    Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
    Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
    Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
    J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
    Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
    Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
    World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.
    Guindalini RSC; Cormedi MCV; Maistro S; Pasini FS; Branas PCAA; Dos Santos L; de Lima Pereira GF; de Bock GH; Saccaro DM; Katayama MLH; Faraj SF; Safatle-Ribeiro A; Ribeiro Junior U; Diz MDPE; de Gouvêa ACRC; Chammas R; Folgueira MAAK
    Gastric Cancer; 2019 Sep; 22(5):920-931. PubMed ID: 30895400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients.
    Muretto P; Ruzzo A; Pizzagalli F; Graziano F; Maltese P; Zingaretti C; Berselli E; Donnarumma N; Magnani M
    Ann Oncol; 2008 Mar; 19(3):516-9. PubMed ID: 17986624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
    Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
    Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.